Johnson & Johnson Readies to Start Covid-19 Vaccine Studies – The Wall Street Journal

Johnson & Johnson said Thursday it plans to begin the first human studies of its experimental coronavirus vaccine next week, as it races to make the shot available starting early next year.

The New Brunswick, N.J., companys initial study will aim to enroll more than 1,000 healthy adults, starting first in Belgium on July 22 and then the following week in the U.S. Researchers will assess the vaccines safety and ability to induce an immune response, J&J Chief Scientific Officer Paul Stoffels said Thursday on a conference...

See the original post here:

Johnson & Johnson Readies to Start Covid-19 Vaccine Studies - The Wall Street Journal

Related Posts
Tags: